04.02.2013 Views

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION<br />

(19) INDIA (21) Application No.: 1268/MUM/2004 A<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application: 25/11/2004 (43) Publication Date: 09/06/2006<br />

(54) Title <strong>of</strong> <strong>the</strong> invention: A PHARMACEUTICAL COMPOSITION<br />

(51) International classification : A61K 9/24,<br />

31/137, C07D<br />

295/088<br />

(31) Priority Document No : NIL<br />

(32) Priority Date : NIL<br />

(33) Name <strong>of</strong> priority country : NIL<br />

(86) International Application No : NIL<br />

and Filing Date : NIL<br />

(87) International Publication No : NIL<br />

(61) Patent <strong>of</strong> addition to :<br />

Application No<br />

NIL<br />

(62)<br />

Filed on : N.A.<br />

Divisional to Application No : NIL<br />

Filed on : N.A.<br />

(71) Name <strong>of</strong> Applicant:<br />

M/S.CIPLA LIMITED<br />

Address <strong>of</strong> <strong>the</strong> Applicant:<br />

289, BELLASIS ROAD, MUMBAI<br />

CENTRAL, MUMBAI-400 008,<br />

MAHARASHTRA, INDIA.<br />

(72) Name <strong>of</strong> <strong>the</strong> Inventor:<br />

LULLA AMAR<br />

MALHOTRA GEENA<br />

Filed U/S 5(2) before The <strong>Patents</strong><br />

(Amendment) Act, 2005: NO<br />

(57) Abstract: The present invention discloses a tablet comprising at least two distinct segments, wherein one<br />

segment comprises predominantly cetirizine, and a portion <strong>of</strong> pseudoephedrine, wherein <strong>the</strong> o<strong>the</strong>r segment<br />

comprises predominantly pseudoephedrine as active ingredients, alongwith pharmaceutically acceptable carrier or<br />

excipients. The invention also discloses <strong>the</strong> process for <strong>the</strong> manufacture <strong>of</strong> <strong>the</strong> tablet. Fur<strong>the</strong>r <strong>the</strong> invention also<br />

describes <strong>the</strong> use <strong>of</strong> <strong>the</strong> tablet for <strong>the</strong> manufacture <strong>of</strong> a medicament for preventing or treating allergic disorders or<br />

conditions associated with rhinitis, cold, flu, cold-like and flu-like symptoms, and allergic rhinitis, relief <strong>of</strong> nasal<br />

congestion, seasonal rhinitis, sneezing, rhinorrhea, nasal and ocular pruritis, redness <strong>of</strong> <strong>the</strong> eyes, tearing and<br />

sneezing.<br />

Drawing Sheets: NIL<br />

Total Pages: 32.<br />

Fig. Nil<br />

The Patent Office Journal 09/06/2006 10926

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!